HOME >> BIOLOGY >> NEWS
Fighting fire with fire? Vaccine based on chimp virus shows promise against HIV

In a new study in mice, a modified form of an innocuous chimpanzee virus has shown marked potency as a protective vaccine against HIV, itself believed to have crossed into the human population from chimpanzees sometime in the 1930s. The study, led by researchers at The Wistar Institute, appears in the February issue of the Journal of Immunology.

"Our results show this new vaccine is capable of inducing the kind of powerful immune response that we and others believe will be critical for controlling HIV infection," says Hildegund C.J. Ertl, M.D., professor and immunology program leader at The Wistar Institute, and senior author on the new study.

Given the history of HIV, Ertl emphasize the lengths to which she and her colleagues have gone to ensure that the new vaccine is completely safe. To eliminate the possibility of any contaminant - an HIV-like stowaway, for example - the vaccine is derived in the laboratory from a set of genetic instructions. Importantly, too, the genes that would be needed by the viral vaccine to replicate are deleted from those instructions.

The vaccine is based on a chimpanzee adenovirus. In chimpanzees and humans, adenoviruses are a common cause of respiratory-tract infections. Immunologists have understood for some time that human adenoviruses can be retooled in the laboratory to serve as the basis for vaccines against an array of viral diseases. They easily enter human cells and stimulate a vigorous, long-lasting immune response. A number of vaccines based on human adenoviruses, including some against HIV, are now in development.

An unaddressed concern with these vaccines, however, is the question of pre-existing immunity. Adenoviruses are nearly ubiquitous among humans, so much so that more than 45 percent of the population has neutralizing antibodies circulating in the blood able to impair any vaccine based on a common human adenovirus. But the new chimpanzee adenovirus vaccine possesses the immunological
'"/>

Contact: Franklin Hoke
hoke@wistar.upenn.edu
215-898-3716
The Wistar Institute
3-Feb-2003


Page: 1 2 3

Related biology news :

1. Fighting Mycobacterium tuberculosis with structural proteomics
2. Fighting the spread of sudden oak death
3. Fighting the battle of the bulge in children
4. Fighting breast cancer at the molecular level
5. Fighting Fungi
6. Fighting skin cancers with computers and technology
7. Fighting diabetes: UD researchers move closer to chip-based control of smart, implantable insulin pumps
8. Trash From Crop-Processing Plant Harvested For Disease-Fighting Agents
9. Studies At Cedars-Sinai Confirm Identity Of An Elusive Receptor In Human Cells -- A Breakthrough In Understanding, Fighting Septic Shock
10. Chemical Contaminants May Inhibit Cancer-Fighting White Blood Cells
11. Radioactive Beads Latest Weapon In Fighting Cancer In Dogs, Cats

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/28/2020)... ... February 26, 2020 , ... ... its patent-pending Rebound PRP™ and Rebound PRF® devices are now available to ... generation of regenerative medical devices, that will provide the most affordable, easiest ...
(Date:2/26/2020)... ... February 25, 2020 , ... Renowned eye surgical practice ... first practices in Texas to offer the FDA-approved, post-surgical, corrective Light Adjustable Lens (LAL) ... been placed with excellent results. Dell Laser Consultants is also currently involved in the ...
(Date:2/13/2020)... ... February 13, 2020 , ... ... Assessment Report: The Laboratory Analytical & Life Science Instrumentation Industry. The report will ... gold standard of market intelligence for the $70 billion laboratory market for analytical ...
Breaking Biology News(10 mins):
(Date:1/24/2020)... ... January 24, 2020 , ... ... RedySmart™ mass flow meters and controllers ideal for BioPharm OEMS. ... upgrade to antiquated rotameters. These thermal instruments employ high-precision MEMS (Micro-Electro Mechanical Systems) ...
(Date:1/22/2020)... Wis. (PRWEB) , ... January 21, 2020 , ... ... the hiring of Darrell Taylor as Southern Midwest Region Industrial and Institutional (I&I) ... the SporActiv™ product line. , Darrell brings over 30 years of ...
(Date:1/10/2020)... ... January 09, 2020 , ... A new report ... for the vendor qualification process, a critical element of clinical trial set up ... of the vendor qualification process creates delays in initiation in 7% of clinical ...
(Date:1/8/2020)... ... January 08, 2020 , ... Anomet Products ... properties for use in harsh environments inside or outside of the human body. ... metals or alloys to achieve specific properties such as corrosion-resistance, biocompatibility, or operation ...
Breaking Biology Technology:
Cached News: